Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.resinv.2020.08.001 http://scihub22266oqcxt.onion/10.1016/j.resinv.2020.08.001 32893160!7455106!32893160     free     free     free       Respir+Investig 2020 ; 58 (6): 430-434 Nephropedia Template TP {{tp|p=32893160|t=2020. Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases |pdf=|usr=}}{{32893160}} gab.com Text Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases JO: Respir Investig http://www.kidney.de/pget.php?&tw=1&pmid=32893160 #FOAvip Although the use of corticosteroids is not recommended in the World Health Organization statement for the treatment of coronavirus disease 2019 (COVID-19), steroid therapy may be indicated for critical cases in specific situations. Here, we report the successful treatment of 11 cases of severe COVID-19 pneumonia with favipiravir and methylprednisolone. All cases were severe and patients required oxygen administration or had a blood oxygen saturation </=93% on room air. All were treated with favipiravir and methylprednisolone, and 10 of 11 patients responded well and required no further oxygen supplementation or ventilator management. This study shows the importance of the early-stage use of a combination of favipiravir and methylprednisolone in severe cases to achieve a favorable clinical outcome. Twit Text FOAVip Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases ????Respir Investig http://www.kidney.de/pget.php?&tw=1&pmid=32893160 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32893160 #FOAvip English Wikipedia <ref>{{Cite pmid|32893160}}</ref> Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases #MMPMID32893160 Murohashi K; Hagiwara E; Kitayama T; Yamaya T; Higa K; Sato Y; Otoshi R; Shintani R; Okabayashi H; Ikeda S; Niwa T; Nakazawa A; Oda T; Okuda R; Sekine A; Kitamura H; Baba T; Komatsu S; Iwasawa T; Kaneko T; Ogura T Respir Investig 2020[Nov]; 58 (6): 430-434 PMID32893160show ga Although the use of corticosteroids is not recommended in the World Health Organization statement for the treatment of coronavirus disease 2019 (COVID-19), steroid therapy may be indicated for critical cases in specific situations. Here, we report the successful treatment of 11 cases of severe COVID-19 pneumonia with favipiravir and methylprednisolone. All cases were severe and patients required oxygen administration or had a blood oxygen saturation |*COVID-19[MESH] |*Methylprednisolone[MESH] |Amides[MESH] |Antiviral Agents/therapeutic use[MESH] |Humans[MESH] |Pyrazines[MESH] |SARS-CoV-2[MESH]Outcome of early-stage combination treatment with favipiravir and met(epmc).pdf DeepDyve Pubget Overpricing